Ritulasta 100 mg Injection
  1. Home
  2. Pharma Products
  3. Plasmagen BioSciences Pvt Ltd
  4. Ritulasta 100 mg Injection

Ritulasta 100 mg Injection

Ritulasta 100 mg Injection contains rituximab, a monoclonal antibody used to treat certain blood cancers and autoimmune conditions. It targets CD20-positive B cells and is used in conditions such as non-Hodgkin lymphoma and chronic lymphocytic leukemia. The medicine is administered by intravenous infusion under the supervision of a qualified healthcare professional.

BUY NOW

Category

Ritulasta 100 mg Injection contains 100 mg of rituximab in a 10 mL presentation. Rituximab binds to the CD20 antigen on B cells, helping reduce targeted B-cell populations. It is administered by intravenous infusion according to the prescribed treatment regimen and clinical condition. The product should be refrigerated at 2°C to 8°C and should not be frozen.

Technical Specification

Specification Details
Active Ingredient Rituximab 100 mg
Concentration 10 mg/mL
Presentation 10 mL Single-Dose Vial
Dosage Form Concentrate for Solution for Infusion
Route of Administration Intravenous
Storage 2°C to 8°C

Product Also Known As

Ritulasta 100 mg Injection, Ritulasta 100 mg/10 mL Injection, Ritulasta Rituximab 100 mg Injection, Rituximab 100 mg Injection, Rituximab 100 mg Infusion, Rituximab Oncology Injection

Related products